Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ From Other Atherosclerotic Disease?

International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms160714477
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Contemporary Use of Lipid-Lowering Therapy for Secondary Prevention in Korean Patients With Atherosclerotic Cardiovascular Diseases

Korean Journal of Internal Medicine
Internal Medicine
2019English

The Role of mHealth Technology in the Secondary Prevention of Cardiovascular Disease

Romanian Biotechnological Letters
2019English

Assessment of Subclinical Atherosclerotic Cardiovascular Disease in Patients With Ankylosing Spondylitis

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2019English

Aspirin Reduces the Risk of Stroke and Other Cardiovascular Events by 25% Among Patients Who Have Had Previous Cardiovascular Disease

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1994English

Omega-6 Fats for the Primary and Secondary Prevention of Cardiovascular Disease

Cochrane Database of Systematic Reviews
2018English

PCSK9 Monoclonal Antibodies for the Primary and Secondary Prevention of Cardiovascular Disease

2015English

Antibiotic Treatment of Atherosclerotic Cardiovascular Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

Stress and Atherosclerotic Cardiovascular Disease

Journal of Atherosclerosis and Thrombosis
BiochemistryInternal MedicineCardiovascular MedicineCardiology
2014English

Critical Challenges of Economic and Social Issues in Secondary Prevention of Cardiovascular Disease

Journal of Family Medicine and Disease Prevention
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy